We are live on
!
Find out more
EC
EcoR1 Capital Portfolio holdings
AUM
$2.34B
1-Year Est. Return
204.53%
This Fund
S&P 500
This Quarter
Est. Return
-10.1%
1 Year Est. Return
+204.53%
3 Year Est. Return
+306.25%
5 Year Est. Return
+490.45%
10 Year Est. Return
+14,115.48%
AUM
$749M
AUM Growth
-$221M
(-23%)
Cap. Flow
-$87.5M
Cap. Flow
% of AUM
-11.68%
Top 10 Holdings %
Top 10 Hldgs %
75.79%
Holding
46
New
9
Increased
6
Reduced
13
Closed
11
Top Buys
| 1 |
Prothena Corp
PRTA
|
+$77.3M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$22.4M |
| 3 |
Solid Biosciences
SLDB
|
+$19M |
| 4 |
Exicure
XCUR
|
+$14.1M |
| 5 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
+$10.1M |
Top Sells
| 1 |
CRISPR Therapeutics
CRSP
|
+$75.8M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$51.9M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
+$23.7M |
| 4 |
Kura Oncology
KURA
|
+$22M |
| 5 |
Gossamer Bio
GOSS
|
+$15.4M |
Sector Composition
| 1 | Healthcare | 83.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Xencor
XNCR
$1.11B
| $84.4M | 11.26% |
2,501,557
+165,000
| +7% | +$6.59M |
|
|
2
Prothena Corp
PRTA
$442M
| $73.9M | 9.86% |
9,426,640
+8,703,340
| +1,203% | +$77.3M |
|
|
ONCE
3
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $69.3M | 9.25% |
714,789
+100,661
| +16% | +$10.1M |
|
|
4
Kura Oncology
KURA
$1.01B
| $61.3M | 8.18% |
4,041,953
-1,234,800
| -23% | -$22M |
|
5
argenx
ARGX
$54.1B
| $60.5M | 8.08% |
531,165
-50,000
| -9% | -$6.76M |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $56.9M | 7.59% |
3,962,978
+646,571
| +19% | +$9.24M |
|
|
KYNB
7
Kyntra Bio
KYNB
$29.8M
| $47.8M | 6.38% |
51,752
-8,719
| -14% | -$9.58M |
|
8
Ironwood Pharmaceuticals
IRWD
$658M
| $40.1M | 5.35% |
4,671,408
| – | – |
|
|
MORF
9
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $39.1M | 5.22% |
2,161,520
-105,284
| -5% | -$2.21M |
|
|
10
Solid Biosciences
SLDB
$945M
| $34.6M | 4.61% |
222,846
+167,713
| +304% | +$19M |
|
|
PRVL
11
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
| $29.4M | 3.92% |
2,392,556
| – | – |
|
|
HARP
12
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $20M | 2.67% |
146,342
+11,500
| +9% | +$1.62M |
|
|
BCEL
13
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $18.1M | 2.42% |
1,481,411
-5,568
| -0.4% | -$84.6K |
|
|
CHMA
14
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $15.1M | 2.01% |
3,043,827
| – | – |
|
|
15
Sarepta Therapeutics
SRPT
$1.86B
| $14.3M | 1.91% |
+189,745
| New | +$22.4M |
|
|
16
Exicure
XCUR
$10.4M
| $14M | 1.86% |
+36,768
| New | +$14.1M |
|
|
EIGR
17
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $10.9M | 1.45% |
35,335
-2,533
| -7% | -$823K |
|
18
Cyclerion Therapeutics
CYCN
$16.3M
| $9.41M | 1.26% |
38,810
| – | – |
|
19
NextCure
NXTC
$26.4M
| $7.73M | 1.03% |
+20,875
| New | +$6.79M |
|
20
Arcus Biosciences
RCUS
$3.52B
| $6.87M | 0.92% |
754,505
-733,700
| -49% | -$5.9M |
|
21
Curis
CRIS
$8.81M
| $6.68M | 0.89% |
7,456
| – | – |
|
22
Neurogene
NGNE
$787M
| $6.46M | 0.86% |
113,294
| – | – |
|
|
MRTX
23
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.44M | 0.46% |
44,221
-553,490
| -93% | -$51.9M |
|
|
MRUS
24
DELISTED
Merus
MRUS
| $2.95M | 0.39% |
+165,600
| New | +$2.72M |
|
|
25
Ultragenyx Pharmaceutical
RARE
$3.13B
| $2.63M | 0.35% |
61,554
-436,345
| -88% | -$23.7M |
|
Similar funds
G
MC
BAM
CC
HFM
NO
ST
MFAM